Gemfibrozil Tablet shortage
Gemfibrozil Tablet is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 22, 2026.
Pfizer is permanently stopping production of gemfibrozil 600 mg tablets. The same medicine — including Lopid (gemfibrozil) 600 mg — is still listed as available from other manufacturers not reporting a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Gemfibrozil Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Feb 10, 2026Currently in shortage1 of 1 product affected.
-
Feb 10, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Pfizer Inc. 📞 800-533-4535 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Lopid, Tablet, 600 mg (NDC 0071-0737-20) | — | — | Discontinuation of the manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Gemfibrozil Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Gemfibrozil Tablet? options further down this page.
Why is Gemfibrozil Tablet in shortage?
Pfizer has let the FDA know that they are permanently stopping the manufacture of their brand-name version of this medication, Lopid, specifically the 600 mg tablet that comes in the package identified as NDC 0071-0737-20. That's the reason this product appears on the shortage list — it won't be coming back from this particular manufacturer.
It's worth knowing that Pfizer did not share a more detailed public explanation for why they made this decision — just that the manufacturing of this specific product is being discontinued. This reflects only Pfizer's Lopid product, so it doesn't speak to what other manufacturers may or may not be doing with their own versions of gemfibrozil.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Gemfibrozil Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Gemfibrozil Tablet?
Gemfibrozil 600 mg tablets are currently listed on the FDA drug-shortage list. The medicine you take comes in one strength, 600 mg, and that strength has no available source from the manufacturer on this record.
The reason reported here is a discontinuation. Pfizer Inc., the maker on this shortage record, has listed its Lopid 600 mg tablet as being discontinued. Because this is a discontinuation rather than a temporary delay, this particular supply problem may be permanent, so a conversation with your prescriber is the right next step. That said, this record reflects only one manufacturer — gemfibrozil 600 mg is still made by several other companies, so the medicine itself may still be available.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check wholesalers and other manufacturers; the same medicine, gemfibrozil 600 mg, is still on the market from makers such as Rising Pharma, Northstar Rx, Camber, Aurobindo, and Chartwell RX, though it may not be in local stock.
- If your pharmacy cannot find it, ask your prescriber or pharmacist about a clinician-chosen option.
Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls.
This is general, national information and may not match your pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Gemfibrozil Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Gemfibrozil Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Lopid | GEMFIBROZIL 600 mg/1 | Tablet, Film Coated · Oral | Parke-Davis Div of Pfizer Inc | 00071-0737-30 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet, Film Coated · Oral | Rising Pharma Holdings, Inc. | 16571-0784-06 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | Northstar RxLLC | 16714-0101-02 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | Camber Pharmaceuticals, Inc. | 31722-0128-05 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | PD-Rx Pharmaceuticals, Inc. | 43063-0745-60 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | A-S Medication Solutions | 50090-5808-00 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet, Film Coated · Oral | A-S Medication Solutions | 50090-7233-00 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | AvPAK | 50268-0350-15 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | American Health Packaging | 60687-0224-01 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet, Film Coated · Oral | Chartwell RX, LLC | 62135-0160-31 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet · Oral | Proficient Rx LP | 63187-0772-30 |
| Gemfibrozil | GEMFIBROZIL 600 mg/1 | Tablet, Film Coated | Aurobindo Pharma Limited | 65862-0624-05 |
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Gemfibrozil 600 mg | Nivagen | 500 tablets | $0.103 | AB | Discontinued |
| Gemfibrozil 600 mg | Rising | 60 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | Northstar | 60 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | Camber | 500 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | AvPAK | 50 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | American | 100 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | Aurobindo | 500 tablets | $0.105 | — | Availability likely |
| Gemfibrozil 600 mg | Cipla | 60 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | NorthStar | 60 tablets | $0.105 | AB | Availability likely |
| Gemfibrozil 600 mg | Exelan | 500 tablets | $0.105 | AB | Availability likely |
| Lopid 600 mg | Parke-Davis | 60 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | NCS | 30 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | PD-Rx | 60 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | A-S | 60 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | A-S | 60 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | A-S | 90 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | A-S | 60 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | A-S | 90 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | A-S | 90 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | Northwind | 90 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | Chartwell | 300 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | Proficient | 30 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | NuCare | 30 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | Coupler | 30 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | NuCare | 60 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | NuCare | 30 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | Zydus | 100 tablets | — | — | FDA listed |
| Gemfibrozil 600 mg | Preferred | 30 tablets | — | AB | FDA listed |
| Gemfibrozil 600 mg | REMEDYREPACK | 45 tablets | — | AB | Discontinued |
| Gemfibrozil 600 mg | REMEDYREPACK | 180 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Gemfibrozil Tablet — that fall in the same broad treatment class (lipotropics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other endocrinology/metabolism shortages
Gemfibrozil Tablet shortage FAQs
Is Gemfibrozil Tablet in shortage?
Which products are affected?
When will Gemfibrozil Tablet be available again?
Can I still get Gemfibrozil somewhere?
What should I do if I take Gemfibrozil Tablet?
Still have a question about the Gemfibrozil Tablet shortage?
Ask a pharmacist about this shortage →View Gemfibrozil Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.